Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Mach7 Technologies ( (AU:M7T) ) has provided an update.
Mach7 Technologies Limited has announced an update on its ongoing share buy-back program, with a total of 5,290,000 ordinary fully paid securities bought back as of June 11, 2025. This strategic move is part of the company’s efforts to optimize its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:M7T) stock is a Buy with a A$0.95 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies Limited operates in the technology industry, focusing on providing innovative healthcare solutions. The company is known for its advanced medical imaging and data management software, which aids healthcare providers in improving patient care and operational efficiency.
Average Trading Volume: 245,556
Technical Sentiment Signal: Sell
Current Market Cap: A$84.43M
Find detailed analytics on M7T stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue